SCHEMBL113179

SCHEMBL113179

Cc1cc(C)n(C(C=O)N2CCC(c3ccccc3-c3cnc(N4CCOCC4)nc3)CC2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.40
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
PDE4B Q07343 1/20 0.38
WDR5 P61964 10/20 0.36
AOC3 Q16853 2/20 0.35
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
TNF P01375 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
GLA P06280 1/20 0.34
CYP2C9 P11712 1/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112035 0.85 CNR2 (0.42) CNR2ALOX5APFEN1WDR5AOC3
SCHEMBL115565 0.81 ALOX5AP (0.41) CNR2ALOX5APFEN1WDR5AOC3
SCHEMBL113141 0.81 CXCR3 (0.38) CNR2ALOX5APFEN1WDR5AOC3
SCHEMBL113998 0.80 AOC3 (0.39) CNR2ALOX5APFEN1WDR5AOC3
SCHEMBL113873 0.78 KDM4E (0.41) WDR5ALDH1A1CYP2C9
SCHEMBL114718 0.77 CXCR3 (0.39) AOC3
SCHEMBL113125 0.77 CXCR3 (0.40) CNR2ALOX5APFEN1AOC3ALDH1A1
SCHEMBL3730827 0.76 CXCR3 (0.51) PDE4BAOC3MEN1ALDH1A1KMT2A
SCHEMBL114041 0.76 CXCR3 (0.39) FEN1AOC3ALDH1A1CASP1
SCHEMBL114405 0.76 CXCR3 (0.39) AOC3MEN1ALDH1A1CYP1A2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed